Mayo Clinic, Rochester, Minnesota.
New York University School of Medicine, New York, New York.
Arthritis Rheumatol. 2017 Dec;69(12):2396-2401. doi: 10.1002/art.40314. Epub 2017 Nov 8.
We describe a 38-year-old woman who presented with a history of inflammatory arthritis, rash, and daily fevers. She was noted to have chronic parvovirus infection with persistently detectable viral titers and a novel mutation in the ELANE gene. ELANE encodes neutrophil elastase, a neutrophil serine protease with important antimicrobial effects, and is found as part of neutrophil extracellular trap (NET) complexes. Pathogenic ELANE mutations have been identified in forms of hereditary neutropenia. However, our patient never had neutropenia. Because of the striking clinical scenario, we investigated this mutation functionally.
NET formation by neutrophils was assessed by scanning electron microscopy. Neutrophil activation and neutrophil elastase production were evaluated by flow cytometry and fluorescent substrate-based functional assay, respectively. A multiplex assay was used to quantitate neutrophil inflammatory cytokine production. PyMOL software was used to generate 3-dimensional models of mutant elastase.
Activated neutrophils from the patient demonstrated a significantly decreased ability to form NETs on scanning electron microscopy, as well as quantitative defects in neutrophil activation and neutrophil elastase activity. The patient's neutrophils showed altered levels of interleukin-12 (IL-12) and IL-8, which are key cytokines for antiviral immunity and neutrophil chemotaxis. Three-dimensional mapping revealed that the mutation could alter protein folding and surface charge distribution, potentially perturbing protein trafficking. Thus, the mutation could affect neutrophil function by decreasing NETosis and altering key antiviral activities of neutrophils.
This is the first report of a human pathogenic ELANE mutation associated with a defect in NETosis and a distinct syndrome of recurrent viral infection and chronic inflammation.
我们描述了一位 38 岁的女性,她有炎症性关节炎、皮疹和每日发热的病史。她被发现患有慢性细小病毒感染,病毒滴度持续可检测,并存在 ELANE 基因的新突变。ELANE 编码中性粒细胞弹性蛋白酶,这是一种具有重要抗菌作用的中性粒细胞丝氨酸蛋白酶,作为中性粒细胞细胞外陷阱(NET)复合物的一部分。遗传性中性粒细胞减少症中已发现致病性 ELANE 突变。然而,我们的患者从未有过中性粒细胞减少症。由于临床表现引人注目,我们对该突变进行了功能研究。
通过扫描电子显微镜评估中性粒细胞形成 NET 的情况。通过流式细胞术和荧光底物功能性测定分别评估中性粒细胞的激活和中性粒细胞弹性蛋白酶的产生。使用多重测定法定量中性粒细胞炎症细胞因子的产生。使用 PyMOL 软件生成突变弹性蛋白酶的 3 维模型。
来自患者的激活中性粒细胞在扫描电子显微镜下显示出形成 NET 的能力显著降低,以及中性粒细胞激活和中性粒细胞弹性蛋白酶活性的定量缺陷。患者的中性粒细胞显示出白细胞介素-12(IL-12)和白细胞介素-8(IL-8)水平的改变,这是抗病毒免疫和中性粒细胞趋化作用的关键细胞因子。三维映射显示,该突变可能改变蛋白质折叠和表面电荷分布,从而可能干扰蛋白质运输。因此,该突变可能通过减少 NETosis 并改变中性粒细胞的关键抗病毒活性来影响中性粒细胞的功能。
这是首例报道的人类致病性 ELANE 突变与 NETosis 缺陷以及复发性病毒感染和慢性炎症的独特综合征相关的病例。